From: Quercetin with the potential effect onĀ allergic diseases
Diseases | Dosage | Animal | Quercetinās effect | References |
---|---|---|---|---|
Allergic asthma | 7.5Ā mg/kg | Male Dunkin-Hartley guinea pigs | Inhibited the sRaw in LAR and IAR dose-dependently, as well as the recruitment of leukocytes, particularly eosinophils and neutrophils on LAR | [21] |
10Ā mg/ml | Male Dunkin-Hartley guinea pigs | Decreased histamine and protein contents, PLA2 activity, and recruitments of leukocytes in BAL fluid and also slightly increased infiltration of eosinophils and neutrophils in histopathological survey | [27] | |
8 or 16Ā mg/kg | BALB/c | Decreased allergic airway inflammation and hyperresponsiveness due to the alteration of Th1/Th2 differentiation via the suppression of GATA-3 and increase of T-bet expression Reduced the increased levels of IL-4, increased IFN-É£, and significantly inhibit all asthmatic reactions | [20] | |
10Ā mg/kg | BALB/c | Reduced eosinophil counts in BALF, blood and lung parenchyma | [29] | |
10Ā mg/kg | BALB/c | Reduced the eosinophil recruitment, IL-4 and IL-5 levels in the BALF, as well as, inhibited the NF-ĪŗB activation, P-selectin expression and the mucus production in the lung | [17] | |
5Ā mg/kg | SpragueāDawley rats | Diminished the increase of total cell numbers and macrophage numbers in BALF Decreased the neutrophil and lymphocyte counts, levels of TNF-Ī±, IL-1Ī², and IL-6 | [30] | |
16Ā mg/kg | BALB/c | Lower epithelial thickness, subepithelial smooth muscle thickness, goblet, and mast cell numbers Lower IL-25, IL-33, TSLP, caspase-3 and TUNEL | [31] | |
Allergic rhinitis | 460Ā mg of herbal extract | Not animals. In AR patients | Reduced total serum IgE | [43] |
25Ā mg/kg | SpragueāDawley rats | Inhibit nasal rubbing movements and sneezing | [44] | |
80Ā mg/kg | SpragueāDawley rats | Suppressed of AR Weaker COX-2 and VIP expressions | [45] | |
Atopic dermatitis | ā | Nc/Nga mouse | Suppressed angiogenesis and Th2-related cytokine expression | [53] |
10Ā mg | Hsd:ICR (CD-1) mice | Amelioration of the tissue damage, with a noticeable attenuation of edema and leukocyte infiltration | [54] | |
2Ā mg | Nc/Nga mouse | Decreased the iNOS and COX-2 mRNA expressions in the skin as well as significantly suppressed the increase in the level of total plasma IgE and eosinophils Down-regulated the expression of the cytokines, IL-4, 5 and 13 | [50] | |
ā | Nc/Nga mouse | Weakened the development of AD-like skin lesions Inhibited hyperkeratosis, parakeratosis, acanthosis, mast cells and infiltration of inflammatory cells Down-regulated cytoplasmic HMGB1, RAGE, nuclear p-NF-ĪŗB, p-extracellular signal-regulated kinase (ERK) 1/2, COX2, TNFĪ±, IL-1Ī², IL-2RĪ±, IFNĪ³ and IL-4 and up-regulated nuclear Nrf2 | [55] |